The companies compete in the home generator business — but this deal involves a different market sector.
Generate Biomedicines filed for an IPO, potentially signaling a stronger 2026 for biotech after a rocky 2025 and testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results